Company news
Lupin Limited (NSE:LUPIN) news
Lupin Limited news releases on 6ix. Latest, Mar 19, 2026: Lupin Limited Press Release Mar 19 2026
Press releases — page 2
Lupin Limited Press Release Mar 19 2026
March 18, 2026
Press Release Mar 17 2026
March 17, 2026
Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025
March 6, 2026
Press Release Feb 27 2026
February 27, 2026
Press Release (Revised) Feb 26 2026
February 26, 2026
Press Release Feb 26 2026
February 26, 2026
Press Release Feb 24 2026
February 24, 2026
Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
February 24, 2026
Press Release Feb 23 2026
February 23, 2026
Press Release Feb 16 2026
February 16, 2026
Press Release Feb 13 2026
February 13, 2026
Press Release Feb 12 2026
February 12, 2026
Press Release Feb 09 2026
February 9, 2026
'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
February 9, 2026
Press Release Feb 04 2026
February 4, 2026
Lupin Launches Topiramate Extended-Release Capsules in the United States
February 4, 2026
Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security
February 4, 2026
Press Release Feb 02 2026
February 2, 2026
Lupin Launches Dasatinib Tablets in the United States
February 2, 2026
Lupin Limited Press Release Feb 02 2026
February 1, 2026
Press Release Jan 23 2026
January 23, 2026
Press Release Jan 21 2026
January 21, 2026
Lupin Limited Press Release Jan 21 2026
January 20, 2026
Press Release Dec 29 2025
December 29, 2025
Press Release Dec 18 2025
December 18, 2025
Press Release Dec 17 2025
December 17, 2025
Press Release Dec 16 2025
December 16, 2025
Lupin Limited Press Release Dec 16 2025
December 15, 2025
Press Release Dec 12 2025
December 12, 2025
Press Release Dec 05 2025
December 5, 2025
Press Release Dec 04 2025
December 4, 2025
Press Release Dec 01 2025
December 1, 2025
Lupin Limited Press Release Dec 01 2025
November 30, 2025
Press Release Nov 28 2025
November 28, 2025
Press Release Nov 15 2025
November 15, 2025
Press Release Nov 14 2025
November 14, 2025
Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
November 14, 2025
Press Release Nov 13 2025
November 13, 2025
Press Release Nov 12 2025
November 12, 2025
Press Release Nov 08 2025
November 8, 2025
Press Release Nov 06 2025
November 6, 2025
Press Release Nov 05 2025
November 5, 2025
Press Release Oct 30 2025
October 30, 2025
Press Release Oct 28 2025
October 28, 2025
Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin's New Corporate Offices in Bridgewater
October 28, 2025
Press Release Oct 24 2025
October 24, 2025
Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing
October 21, 2025
Press Release Oct 13 2025
October 13, 2025
Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025
October 13, 2025
Press Release Oct 09 2025
October 9, 2025